Back to Search
PHILIP FELDMAN, MD
MD
Psychiatry Physician
NPI: 1821144395Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
MD00755418(NJ)
Research & Publications (20)
Medication management: evidence brief. Center for Home Care Policy & Research.
PMID 19509525·Home Healthc Nurse·2009
6-review
Understanding the complexity of hypertensive African American home care patients: challenges to intervention.
PMID 19537225·Ethn Dis·2009
8-other
Promoting excellence in geriatric home care: proceedings and findings from a national conference.
PMID 19507360·Caring·2009
8-other
The effect of an area-based intervention on breastfeeding rates in Victoria, Australia.
PMID 18829128·Health Policy·2009
8-other
The effects of an area-based intervention on the uptake of maternal and child health assessments in Australia: a community trial.
PMID 19320980·BMC Health Serv Res·2009
4-observational
Sources of stress in impoverished neighbourhoods: insights into links between neighbourhood environments and health.
PMID 19236355·Aust N Z J Public Health·2009
8-other
Pharmacological characterization of INCB3344, a small molecule antagonist of human CCR2.
PMID 19576173·Biochem Biophys Res Commun·2009
8-other
People, places and policies - trying to account for health inequalities in impoverished neighbourhoods.
PMID 19236354·Aust N Z J Public Health·2009
8-other
Comparison of symptomatic versus functional changes in children and adolescents with ADHD during randomized, double-blind treatment with psychostimulants, atomoxetine, or placebo.
PMID 19309330·J Child Psychol Psychiatry·2009
4-observational
Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome.
PMID 17934184·J Atten Disord·2008
2-rct
CYP2D6 metabolizer status and atomoxetine dosing in children and adolescents with ADHD.
PMID 17698328·Eur Neuropsychopharmacol·2008
3-trial
PPAR modulators and PPAR pan agonists for metabolic diseases: the next generation of drugs targeting peroxisome proliferator-activated receptors?
PMID 18537685·Curr Top Med Chem·2008
6-review
Sustainability of partnership projects: a conceptual framework and checklist.
PMID 18277638·Jt Comm J Qual Patient Saf·2007
8-other
ReACH National Demonstration Collaborative: early results of implementation.
PMID 18032203·Home Health Care Serv Q·2007
8-other
Effect of two different methods of initiating atomoxetine on the adverse event profile of atomoxetine.
PMID 17450047·J Am Acad Child Adolesc Psychiatry·2007
4-observational
Prevalence, diagnosis, and treatment of ankyloglossia: methodologic review.
PMID 17872781·Can Fam Physician·2007
6-review
Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
PMID 17692731·Clin Ther·2007
3-trial
Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatment.
PMID 17979588·J Child Adolesc Psychopharmacol·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6 WHITE HORSE PIKE
HADDON HEIGHTS, NJ 08035 - Phone
- (856) 547-2822
Quick Facts
- NPI
- 1821144395
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile